Declining rates of hepatocellular carcinoma in urban Shanghai: Incidence trends in 1976-2005

European Journal of Epidemiology

Volumn 27, Issue 1, 2012, Pages 39-46

  Gao, Shan ^a,b   Yang, Wan Shui ^a,b   Bray, Freddie ^c   Va, Puthiery ^d   Zhang, Wei ^a,b   Gao, Jing ^a,b   Xiang, Yong Bing ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d UNIVERSITY OF NEW ENGLAND   (United States)

Author keywords

Age period cohort analysis; Hepatocellular carcinoma; Incidence; Shanghai; Time Trend

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BIRTH RATE; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER REGISTRY; CANCER RISK; CHILD; CHINA; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SCHOOL CHILD; SEX DIFFERENCE; TREND STUDY; URBAN AREA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; CHINA; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LIVER NEOPLASMS; MALE; MIDDLE AGED; MODELS, STATISTICAL; POISSON DISTRIBUTION; REGISTRIES; REGRESSION ANALYSIS; URBAN HEALTH; YOUNG ADULT;

EID: 84857993173     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-011-9636-8     Document Type: Article

References (39)

1. International Agency for Research on Cancer. GLOBOCAN 2008: cancer incidence and mortality worldwide in 2008. 2008. Cited 2010 December 1. Available from: http://globocan.iarc.fr/factsheets/populations.
2. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P. Cancer incidence in five continents, vol. IX. Lyon: IARC Scientific Publications; 2007. vol. 160, pp. 1-897.
3. International Agency for Research on Cancer. Cancer incidence in five continents. 2010 [Internet] [cited 2010 December 3]. Available from URL: http://ci5.iarc.fr/.
4. The Shanghai Cancer Registry. The incidence rates of malignant tumors in urban Shanghai, 2007. Tumor (Shanghai) 2010;30:726.
5. Clayton D, Schifflers E. Models for temporal variation in cancer rates I: age-period and age-cohort models. Stat Med. 1987;6(4): 449-67. (Pubitemid 17110908)
6. Clayton D, Schifflers E. Models for temporal variation in cancer rates II: age- period- cohort models. Stat Med. 1987;6(4):469-81. (Pubitemid 17110909)
7. Lee LT, Huang HY, Huang KC, Chen CY, Lee WC. Age-periodcohort analysis of hepatocellular carcinoma mortality in Taiwan, 1976-2005. Ann Epidemiol. 2009;19(5):323-8.
8. Dal Maso L, Lise M, Zambon P, Crocetti E, Serraino D, Ricceri F, Vercelli M, De Lisi V, Tagliabue G, Federico M, Falcini F, Cassetti T, et al. Incidence of primary liver cancer in Italy between 1988 and 2002: an age-period-cohort analysis. Eur J Cancer. 2008;44(2):285-92.
9. Gao YT, Lu W. Cancer incidence, mortality and survival rates in urban Shanghai (1973-2000). Shanghai: Second Military Medical University Press; 2007. p. 443.
10. Carstensen B. Age-period cohort models for the Lexis diagram. Stat Med. 2007;26(15):3018-45. (Pubitemid 46939424)
11. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents, vol. VIII. Lyon, France: IARC Science Publication; 2002. vol. 155, pp. 1-781.
12. Hankey BF, Ries LA, Kosary CL, Feuer EJ, Merrill RM, Clegg LX, Edwards BK. Partitioning linear trends in age-adjusted rates. Cancer Cause Control. 2000;11(1):31-5.
13. Viel JF, Fournier E, Danzon A. Age-period-cohort modeling of non-Hodgkin's lymphoma incidence in a French region: a period effect compatible with an environmental exposure. Environ Health. 2010;9:47.
14. Zong ZH, Shen QJ, Chen JG, Li WG, Yao HY. Application of Bayesian graphical modeling to analysis of the incidence data of primary liver cancer in Qidong county. Chin J Health Stat. 2005;22:13-5.
15. Shen QJ, Zhang XF, Chen JG, Li WG, Yao HY. An age-periodcohort modeling study on primary liver cancer incidence rate in Qidong. Clin J Epidemiol. 2004;25:902-4.
16. R Development Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2010. ISBN 3-900051-07-0. [Internet] 2010 [cited 2010 December 3]. Available from: http://www.Rproject.org.
17. Carstensen B, Plummer M, Laara E, Hills M, et al. Epi: a package for statistical analysis in epidemiology. R package version 1.1.17. 2010. [Internet] [cited 2010 December 3]. Available from: http://CRAN.R-project.org/package=Epi.
18. Chuang SC, La Vecchia C, Boffetta P. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett. 2009;286(1):9-14.
19. Veldt BJ, Chen W, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, de Knegt RJ, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes. Hepatology. 2008;47(6):1856-62 .
20. Lu F, Zhuan H. Prevention of hepatitis B in China: achievements and challenges. Chin Med J. 2009;122:2925-7.
21. Barazani Y, Hiatt JR, Tong MJ, Busuttil RW. Chronic viral hepatitis and hepatocellular carcinoma. World J Surg. 2007; 31(6):1243-8. (Pubitemid 47029929)
22. Yao GB. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut. 1996;38(Suppl 2):S39-42. (Pubitemid 26167504)
23. Li YT, Wu HY, Zhang AX, Shen WJ, Yuan GJ. Epidemiological effect observed after hepatitis B immunization of newborns in different regions in Shanghai. Shanghai J Prev Med. 2000;12: 410-1.
24. Lu W, Zheng Y. Prevalence and prevention measure of cancer in Shanghai. China Cancer. 2009;18:90-1.
25. Zhang AX, Li YT, Xu Q, et al. Review and measures of hepatitis B immunization in Shanghai. Shanghai J Prev Med. 2000;12: 408-10.
26. Castells L, Vargas V, Gonzalez A, Esteban J, Esteban R, Guardia J. Long interval between HCV infection and the development of hepatocellular carcinoma. Liver. 1995;15(3):159-63.
27. Zhao SJ, Xu ZY, Lu Y. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in China. Int J Epidemiol. 2000;29(4):744-52. (Pubitemid 30612243)
28. Lu W, Li DL, Zheng Y. Conception of cancer prevention and control strategy in Shanghai. China Cancer. 2001;10:187-8.
29. Wang J, Liu XM. Assessment of dietary aflatoxins exposure in Chinese residents. Chin J Food Hygiene. 2007;19(3):238-40.
30. Yeh FS, Shen KN. Epidemiology and early diagnosis of primary liver cancer in China. Adv Cancer Res. 1986;47:297-329.
31. China Cancer Prevention and Treatment Office. The diagnostic standard on primary liver cancer. Chin J Hepato Surg. 1998; 4:103.
32. Keyes KM, Utz RL, Robinson W, Li GH. What is a cohort effect? Comparison of three statistical methods for modeling cohort effects in obesity prevalence in the United States, 1971-2006. Soc Sci Med. 2010;70(7):1100-8.
33. Reimers LL, Anderson WF, Rosenberg PS, Henson DE, Castle PE. Etiological heterogeneity for cervical carcinoma by histopathological type, using comparative age-period-cohort (APC) models. Cancer Epidemiol Biomarkers Prev. 2009;18(3):792-800.
34. Jia WH, Huang QH, Liao J, et al. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China. BMC Cancer. 2006;6:178.
35. Gao S, Yang WS, Gao J, Wang J, Xiang YB. A Meta-analysis of cohort studies on the association between diabetes and the risk of primary liver cancer. Chin J Prev Med. 2010;44(8):711-6.
36. Lai MS, Hsieh MS, Chiu YH, Chen TH. Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology. 2006;43(6):1295-302. (Pubitemid 43980108)
37. Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, Tanaka E. Hepatocellular carcinoma: recent trends in Japan. Gastroenterology. 2004;127(5 Suppl 1):S17-26. (Pubitemid 39423366)
38. Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF Jr. Relation of body mass index to cancer risk in 362, 552 Swedish men. Cancer Causes Control. 2006;17(7):901-9. (Pubitemid 44078281)
39. Ohishi W, Fujiwara S, Cologne JB, Suzuki G, Akahoshi M, Nishi N, Takahashi I, Chayama K. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study. Cancer Epidemiol Biomarkers Prev. 2008;17(4):846-54. (Pubitemid 351536415)